Modulation of Gut Microbiota and Glucose Homeostasis through High-Fiber Dietary Intervention in Type 2 Diabetes Management
DOI:
https://doi.org/10.53469/wjimt.2024.07(06).04Keywords:
Dietary fiber intervention, Gut microbiome diversity, Glucose metabolism regulation, Short-chain fatty acid production, Type 2 diabetes therapeutic strategyAbstract
This study investigates the role of dietary modulation in shaping gut microbiota and its subsequent effects on metabolic regulation in individuals with type 2 diabetes mellitus (T2DM). Over an 8-week period, participants were divided into four dietary groups (CS, TS, CE, and TE), with the TE group receiving a high-fiber diet designed to support diverse microbial growth. Analysis showed a 24% increase in microbial richness in the TE group, achieving 235 observed OTUs at a sequencing depth of 30,000 reads, in contrast to 190 OTUs in the control group (CS). The TE group also exhibited a Gini-Simpson index of 0.88, indicating a balanced microbial ecosystem with reduced dominance of specific taxa, compared to 0.72 in the CS group. Principal Coordinates Analysis (PCoA) demonstrated a distinct microbial clustering in the TE group, reflecting a community composition associated with enhanced metabolic stability. Metabolically, the TE group showed an 18% reduction in fasting blood glucose (FBG) and a 15% increase in serum insulin, underscoring the high-fiber diet’s role in promoting glucose homeostasis. These findings underscore the therapeutic potential of dietary strategies in modulating microbiota for improved metabolic outcomes in T2DM. Further investigation into these mechanistic pathways is recommended to refine dietary interventions for metabolic health.
References
Vignesh, A., Amal, T. C., Sarvalingam, A., & Vasanth, K. (2024). A Review on the Influence of Nutraceuticals and Functional Foods on Health. Food Chemistry Advances, 100749.
Gerontiti, E., Shalit, A., Stefanaki, K., Kazakou, P., Karagiannakis, D. S., Peppa, M., ... & Paschou, S. A. (2024). The role of low glycemic index and load diets in medical nutrition therapy for type 2 diabetes: an update. Hormones, 1-11.
Peredo-Lovillo, A., Romero-Luna, H. E., & Jiménez-Fernández, M. (2020). Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism. Food Research International, 136, 109473.
Li, W. (2022, April). Rural-to-Urban Migration and Overweight Status in Low-and Middle-Income Countries: Evidence From Longitudinal Data in Indonesia. In PAA 2022 Annual Meeting. PAA.
Beteri, B., Barone, M., Turroni, S., Brigidi, P., Tzortzis, G., Vulevic, J., ... & Costabile, A. (2024). Impact of Combined Prebiotic Galacto-Oligosaccharides and Bifidobacterium breve-Derived Postbiotic on Gut Microbiota and HbA1c in Prediabetic Adults: A Double-Blind, Randomized, Placebo-Controlled Study. Nutrients, 16(14).
Masarova, L., Verstovsek, S., Liu, T., Rao, S., Sajeev, G., Fillbrunn, M., ... & Signorovitch, J. (2024). Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM. Future Oncology, 1-12.
Archana, Gupta, A. K., Noumani, A., Panday, D. K., Zaidi, F., Sahu, G. K., ... & Solanki, P. R. (2024). Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update. Cell Biochemistry and Function, 42(7), e4108.
Li, W. (2022). How Urban Life Exposure Shapes Risk Factors of Non-Communicable Diseases (NCDs): An Analysis of Older Rural-to-Urban Migrants in China. Population Research and Policy Review, 41(1), 363-385.
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., ... & Reddy, P. H. (2022). Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radical Biology and Medicine, 184, 114-134.
Wang, Y., Xu, Z., Wu, K. L., Yu, L., Wang, C., Ding, H., ... & Xiao, H. (2024). Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. Proceedings of the National Academy of Sciences, 121(5), e2312929121.
Wang, Y., Wang, C., Xia, M., Tian, Z., Zhou, J., Berger, J. M., ... & Xiao, H. (2024). Engineering Small Molecule and Protein Drugs for Targeting Bone Tumors. Molecular Therapy.
Jacquier, E. F., van de Wouw, M., Nekrasov, E., Contractor, N., Kassis, A., & Marcu, D. (2024). Local and Systemic Effects of Bioactive Food Ingredients: Is There a Role for Functional Foods to Prime the Gut for Resilience?. Foods, 13(5), 739.
Cheng, L., Wang, Y., Guo, Y., Zhang, S. S., & Xiao, H. (2024). Advancing protein therapeutics through proximity-induced chemistry. Cell Chemical Biology, 31(3), 428-445.
Bergia III, R. E., Biskup, I., Giacco, R., Costabile, G., Gray, S., Wright, A., ... & Riccardi, G. (2020). The MEDGICarb-Study: Design of a multi-center randomized controlled trial to determine the differential health-promoting effects of low-and high-glycemic index Mediterranean-style eating patterns. Contemporary clinical trials communications, 19, 100640.
Ding, Y., Pedersen, S. S., Wang, Y., Xiao, H., & Ball, Z. T. (2024). Ex Situ Gaseous Reagent for Multicomponent Amine Bioconjugation. Organic Letters.
Das, S. K., Gilhooly, C. H., Golden, J. K., Pittas, A. G., Fuss, P. J., Cheatham, R. A., ... & Roberts, S. B. (2007). Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. The American journal of clinical nutrition, 85(4), 1023-1030.
Jayalakshmi, G. (2023). CORRELATIVE STUDY OF INSULIN RESISTANCE AND PANCREATIC BETA CELL FUNCTION IN DIABETICS AND NON-DIABETICS.
Kohnert, E., Kreutz, C., Binder, N., Hannibal, L., Gorkiewicz, G., Müller, A., ... & Lederer, A. K. (2021). Changes in gut microbiota after a four-week intervention with vegan vs. meat-rich diets in healthy participants: A randomized controlled trial. Microorganisms, 9(4), 727.
Chen, Y., Jin, S., Zhang, M., Hu, Y., Wu, K. L., Chung, A., ... & Xiao, H. (2022). Unleashing the potential of noncanonical amino acid biosynthesis to create cells with precision tyrosine sulfation. Nature Communications, 13(1), 5434.
Leal-Witt, M. J., Ramon-Krauel, M., Samino, S., Llobet, M., Cuadras, D., Jimenez-Chillaron, J. C., ... & Lerin, C. (2018). Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity. International Journal of Obesity, 42(1), 72-78.
Wichman, C., Smith, L. M., & Yu, F. (2021). A framework for clinical and translational research in the era of rigor and reproducibility. Journal of Clinical and Translational Science, 5(1), e31.
Daisley, B. A., Koenig, D., Engelbrecht, K., Doney, L., Hards, K., Al, K. F., ... & Burton, J. P. (2021). Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases. Cell reports, 37(10).
Guo, Y., Cheng, L., Hu, Y., Zhang, M., Liu, R., Wang, Y., ... & Xiao, H. (2024). Biosynthesis of Halogenated Tryptophans for Protein Engineering using Genetic Code Expansion. ChemBioChem, e202400366.
Ding, Y., Pedersen, S. S., Wang, H., Xiang, B., Wang, Y., Yang, Z., ... & Ball, Z. T. (2024). Selective Macrocyclization of Unprotected Peptides with an Ex Situ Gaseous Linchpin Reagent. Angewandte Chemie International Edition, e202405344.
Chen, S., Wang, Y., Zhong, M., Yu, D., Wang, C., & Lu, X. (2019). Fe (III)-tannic acid complex derived Fe3C decorated carbon nanofibers for triple-enzyme mimetic activity and their biosensing application. ACS Biomaterials Science & Engineering, 5(3), 1238-1246.
Shen, Q., Li, Z., Wang, Y., Meyer, M. D., De Guzman, M. T., Lim, J. C., ... & Lu, G. J. (2024). 50‐nm Gas‐Filled Protein Nanostructures to Enable the Access of Lymphatic Cells by Ultrasound Technologies. Advanced Materials, 2307123.